| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3180081 | Actas Dermo-Sifiliográficas | 2013 | 8 Pages |
Abstract
In our experience, topical PUVA is an appropriate treatment alternative for palmoplantar psoriasis; it offers similar response rates to systemic treatments, but has a better tolerance and safety profile. Associated systemic treatment, with acitretin in most cases, improved the probability of a satisfactory response to PUVA and should be considered in patients who do not respond adequately after 8 to 10 sessions.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
J.M. Carrascosa, A. Plana, C. Ferrándiz,